Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox

被引:33
|
作者
Koonin, Eugene V. [2 ]
Gootenberg, Jonathan S. [1 ]
Abudayyeh, Omar O. [1 ]
机构
[1] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA
[2] Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD 20894 USA
基金
美国国家卫生研究院;
关键词
ALTERED PAM SPECIFICITIES; RNA-GUIDED ENDONUCLEASE; NUCLEIC-ACID DETECTION; IN-VIVO; STRUCTURAL BASIS; EVOLUTIONARY CLASSIFICATION; DETECTION PLATFORM; PROTEIN CLEAVAGE; TARGETING RANGE; DENGUE VIRUS;
D O I
10.1021/acs.biochem.3c00159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPRsystems mediate adaptive immunity in bacteria and archaeathrough diverse effector mechanisms and have been repurposed for versatileapplications in therapeutics and diagnostics thanks to their facilereprogramming with RNA guides. RNA-guided CRISPR-Cas targeting andinterference are mediated by effectors that are either componentsof multisubunit complexes in class 1 systems or multidomain single-effectorproteins in class 2. The compact class 2 CRISPR systems have beenbroadly adopted for multiple applications, especially genome editing,leading to a transformation of the molecular biology and biotechnologytoolkit. The diversity of class 2 effector enzymes, initially limitedto the Cas9 nuclease, was substantially expanded via computationalgenome and metagenome mining to include numerous variants of Cas12and Cas13, providing substrates for the development of versatile,orthogonal molecular tools. Characterization of these diverse CRISPReffectors uncovered many new features, including distinct protospaceradjacent motifs (PAMs) that expand the targeting space, improved editingspecificity, RNA rather than DNA targeting, smaller crRNAs, staggeredand blunt end cuts, miniature enzymes, promiscuous RNA and DNA cleavage,etc. These unique properties enabled multiple applications, such asharnessing the promiscuous RNase activity of the type VI effector,Cas13, for supersensitive nucleic acid detection. class 1 CRISPR systemshave been adopted for genome editing, as well, despite the challengeof expressing and delivering the multiprotein class 1 effectors. Therich diversity of CRISPR enzymes led to rapid maturation of the genomeediting toolbox, with capabilities such as gene knockout, base editing,prime editing, gene insertion, DNA imaging, epigenetic modulation,transcriptional modulation, and RNA editing. Combined with rationaldesign and engineering of the effector proteins and associated RNAs,the natural diversity of CRISPR and related bacterial RNA-guided systemsprovides a vast resource for expanding the repertoire of tools formolecular biology and biotechnology.
引用
收藏
页码:3465 / 3487
页数:23
相关论文
共 50 条
  • [21] Finally, Archaea Get Their CRISPR-Cas Toolbox
    Gophna, Uri
    Allers, Thorsten
    Marchfelder, Anita
    TRENDS IN MICROBIOLOGY, 2017, 25 (06) : 430 - 432
  • [22] CRISPR-Cas systems for genome editing of mammalian cells
    Mani, Indra
    Arazoe, Takayuki
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 15 - 30
  • [23] The CRISPR-Cas toolbox and gene editing technologies
    Liu, Guanwen
    Lin, Qiupeng
    Jin, Shuai
    Gao, Caixia
    MOLECULAR CELL, 2022, 82 (02) : 333 - 347
  • [24] Harnessing CRISPR-Cas systems for bacterial genome editing
    Selle, Kurt
    Barrangou, Rodolphe
    TRENDS IN MICROBIOLOGY, 2015, 23 (04) : 225 - 232
  • [25] Development of CRISPR-Cas systems for genome editing and beyond
    Zhang, F.
    QUARTERLY REVIEWS OF BIOPHYSICS, 2019, 52
  • [26] CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
    Karpov, Dmitry S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [27] CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
    Martel, Bruno
    Moineau, Sylvain
    NUCLEIC ACIDS RESEARCH, 2014, 42 (14) : 9504 - 9513
  • [28] The CRISPR-Cas system - from bacterial immunity to genome engineering
    Czarnek, Maria
    Bereta, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 901 - 916
  • [29] Phage Genetic Engineering Using CRISPR-Cas Systems
    Hatoum-Aslan, Asma
    VIRUSES-BASEL, 2018, 10 (06):
  • [30] Chemical engineering of CRISPR-Cas systems for therapeutic application
    Barber, Halle M.
    Pater, Adrian A.
    Gagnon, Keith T.
    Damha, Masad J.
    O'Reilly, Daniel
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 209 - 230